blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1442024

EP1442024 - AMINOBENZAMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3$g(b) INHIBITORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  20.09.2013
Database last updated on 18.11.2024
Most recent event   Tooltip20.09.2013No opposition filed within time limitpublished on 23.10.2013  [2013/43]
20.09.2013Change - no opposition filedpublished on 23.10.2013  [2013/43]
Applicant(s)For all designated states
Janssen Pharmaceutica NV
Turnhoutseweg 30
2340 Beerse / BE
[2008/12]
Former [2004/32]For all designated states
JANSSEN PHARMACEUTICA N.V.
Turnhoutsebaan 30
2340 Beerse / BE
Inventor(s)01 / FREYNE, Eddy J. E., Janssen Pharmaceutica N.V.
Turnhoutseweg 30
B-2340 Beerse / BE
02 / BUIJNSTERS, Peter J. J. A., Janssen Pharmaceutica N.V.
Turnhoutseweg 30
B-2340 Beerse / BE
03 / WILLEMS, Marc, Janssen Pharmaceutica N.V.
Turnhoutseweg 30
B-2340 Beerse / BE
04 / EMBRECHTS, Werner C. J., Janssen Pharmaceutica N.V.
Turnhoutseweg 30
B-2340 Beerse / BE
05 / JANSSEN, Paul A. J. (deceased)
/ BE
06 / LEWI, Paulus Joannes, Janssen Pharmaceutica N.V.
Turnhoutseweg 30
B-2340 Beerse / BE
07 / HEERES, Jan, Janssen Pharmaceutica N.V.
Turnhoutseweg 30
B-2340 Beerse / BE
08 / DE JONGE, Marc R., Janssen Pharmaceutica N.V.
Turnhoutseweg 30
B-2340 Beerse / BE
09 / KOYMANS, Lucien M. H., Janssen Pharmaceutica N.V.
Turnhoutseweg 30
B-2340 Beerse / BE
10 / DAEYAERT, Frederik F. D., Janssen Pharmaceutica N.V.
Turnhoutseweg 30
B-2340 Beerse / BE
11 / KUKLA, Michael J.
1551 Oak Hollow Drive
Maple Glen, PA 19002 / US
12 / GEERTS, Hugo A. G.
686 Westwind Drive
Berwyn, PA 19312 / US
13 / NUYDENS, Rony M., Janssen Pharmaceutica N.V.
Turnhoutseweg 30
B-2340 Beerse / BE
14 / MERCKEN, Marc H., Janssen Pharmaceutica N.V.
Turnhoutseweg 30
B-2340 Beerse / BE
15 / LUDOVICI, Donald W., Janssen Pharmaceutica Inc.
1125 Trenton-Harbourton Road
Titusville, NJ 08560 / US
16 / JANSSEN, Jasmine, Josee, Werner
Zinkvalstraat 5
B-2360 Aartselaar / BE
17 / JANSSEN, Maroussia, Godelieve, Frank
Dreve du Carmel 17
B-1410 Waterloo / BE
18 / JANSSEN, Paul, Peter, Maria
Grotesteenweg-Zuid 4
B-9052 Zwijnaarde / BE
19 / ARTS, Theodora, Joanna, Francisca
Antwerpsesteenweg 20
B-2350 Vosselaar / BE
20 / JANSSEN, Herwig, Josephus, Margareta
Koekoeksdreef 47
B-2970 Schide / BE
 [2008/07]
Former [2004/32]01 / FREYNE, Eddy J. E., Janssen Pharma. N.V.
Turnhoutseweg 30
B-2340 Beerse / BE
02 / BUIJNSTERS, Peter J. J. A., Janssen Pharma. N.V.
Turnhoutseweg 30
B-2340 Beerse / BE
03 / WILLEMS, Marc, Janssen Pharma. N.V.
Turnhoutseweg 30
B-2340 Beerse / BE
04 / EMBRECHTS, Werner C. J., Janssen Pharma. N.V.
Turnhoutseweg 30
B-2340 Beerse / BE
05 / JANSSEN, Paul A. J. (deceased)
/ BE
06 / LEWI, Paulus Joannes, Janssen Pharma. N.V.
Turnhoutseweg 30
B-2340 Beerse / BE
07 / HEERES, Jan, Janssen Pharma. N.V.
Turnhoutseweg 30
B-2340 Beerse / BE
08 / DE JONGE, Marc R., Janssen Pharma. N.V.
Turnhoutseweg 30
B-2340 Beerse / BE
09 / KOYMANS, Lucien M. H., Janssen Pharma. N.V.
Turnhoutseweg 30
B-2340 Beerse / BE
10 / DAEYAERT, Frederik F. D., Janssen Pharma. N.V.
Turnhoutseweg 30
B-2340 Beerse / BE
11 / KUKLA, Michael J.
1551 Oak Hollow Drive
Maple Glen, PA 19002 / US
12 / GEERTS, Hugo A. G.
686 Westwind Drive
Berwyn, PA 19312 / US
13 / NUYDENS, Rony M., Janssen Pharma. N.V.
Turnhoutseweg 30
B-2340 Beerse / BE
14 / MERCKEN, Marc H., Janssen Pharma. N.V.
Turnhoutseweg 30
B-2340 Beerse / BE
15 / LUDOVICI, Donald W., Janssen Pharma. Inc.
1125 Trenton-Harbourton Road
Titusville, NJ 08560 / US
16 / JANSSEN, Jasmine, Josee, Werner
Zinkvalstraat 5
B-2360 Aartselaar / BE
17 / JANSSEN, Maroussia, Godelieve, Frank
Dreve du Carmel 17
B-1410 Waterloo / BE
18 / JANSSEN, Paul, Peter, Maria
Grotesteenweg-Zuid 4
B-9052 Zwijnaarde / BE
19 / ARTS, Theodora, Joanna, Francisca
Antwerpsesteenweg 20
B-2350 Vosselaar / BE
20 / JANSSEN, Herwig, Josephus, Margareta
Koekoeksdreef 47
B-2970 Schide / BE
Application number, filing date02802307.529.10.2002
[2004/32]
WO2002EP12079
Priority number, dateEP2001020419201.11.2001         Original published format: EP 01204192
[2004/32]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO03037877
Date:08.05.2003
Language:EN
[2003/19]
Type: A1 Application with search report 
No.:EP1442024
Date:04.08.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 08.05.2003 takes the place of the publication of the European patent application.
[2004/32]
Type: B1 Patent specification 
No.:EP1442024
Date:19.03.2008
Language:EN
[2008/12]
Search report(s)International search report - published on:EP08.05.2003
ClassificationIPC:C07D239/30, C07D239/46, C07D239/48, C07D403/10, A61K31/506, A61P3/10, A61P25/28
[2004/32]
CPC:
C07D239/42 (EP,US); C07D239/46 (KR); A61K31/506 (EP,US);
A61P17/00 (EP); A61P21/04 (EP); A61P25/00 (EP);
A61P25/04 (EP); A61P25/16 (EP); A61P25/18 (EP);
A61P25/24 (EP); A61P25/28 (EP); A61P29/00 (EP);
A61P3/10 (EP); A61P35/00 (EP); A61P43/00 (EP);
A61P7/00 (EP); C07D239/47 (EP,US); C07D239/48 (EP,US);
C07D239/50 (EP,US); C07D403/12 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2004/32]
Extension statesAL01.06.2004
LT01.06.2004
LV01.06.2004
MK01.06.2004
RO01.06.2004
SI01.06.2004
TitleGerman:AMINOBENZAMIDDERIVATE ALS INHIBITOREN DER GLYCOGENSYNTHASEKINASE-3-[2004/32]
English:AMINOBENZAMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3$g(b) INHIBITORS[2004/32]
French:DERIVES D'AMINOBENZAMIDE UTILES COMME INHIBITEURS DE LA GLYCOGENE SYNTHASE KINASE 3$G(B)[2004/32]
Entry into regional phase01.06.2004National basic fee paid 
01.06.2004Designation fee(s) paid 
01.06.2004Examination fee paid 
Examination procedure10.04.2003Request for preliminary examination filed
International Preliminary Examining Authority: EP
01.06.2004Examination requested  [2004/32]
05.11.2004Despatch of a communication from the examining division (Time limit: M06)
04.05.2005Reply to a communication from the examining division
29.03.2006Despatch of a communication from the examining division (Time limit: M04)
28.07.2006Reply to a communication from the examining division
10.09.2007Communication of intention to grant the patent
07.01.2008Fee for grant paid
07.01.2008Fee for publishing/printing paid
Opposition(s)22.12.2008No opposition filed within time limit [2009/09]
22.12.2008No opposition filed within time limit [2013/43]
Fees paidRenewal fee
02.11.2004Renewal fee patent year 03
31.10.2005Renewal fee patent year 04
31.10.2006Renewal fee patent year 05
31.10.2007Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY19.03.2008
CZ19.03.2008
EE19.03.2008
SK19.03.2008
BG19.06.2008
MC31.10.2008
[2009/42]
Former [2009/25]CZ19.03.2008
EE19.03.2008
SK19.03.2008
BG19.06.2008
MC31.10.2008
Former [2009/23]CZ19.03.2008
EE19.03.2008
SK19.03.2008
BG19.06.2008
Former [2009/22]CZ19.03.2008
EE19.03.2008
SK19.03.2008
Former [2008/50]CZ19.03.2008
SK19.03.2008
Cited inInternational search[DA]EP0162204  (GRIMME LANDMASCHF FRANZ [DE]) [DA] 1 * R1 is phenyl substituted by CONH2;; claim 1 *;
 [DX]EP0233461  (AMERICAN CYANAMID CO [US]) [DX] 1 * R2 is phenyl substituted by CONH(CH2)nNRR;; example 266; claim 1 *;
 [DX]EP0337943  (CIBA GEIGY AG [CH]) [DX] 1 * Compounds (II);; example 2.687; claim 7 *;
 [DA]WO9118887  (SMITHKLINE BEECHAM INTERCREDIT [NL]) [DA] 1 * claim 1 *;
 [DX]US5516775  (ZIMMERMANN JUERG [CH], et al) [DX] 1 * example F; claim 1 *;
 [DX]EP0945443  (JANSSEN PHARMACEUTICA NV [BE]) [DX] 1 * Page 8, lines 31 and 40. *;
 [X]WO9965897  (CHIRON CORP [US], et al) [X] 1-14 * Compounds where one of R5 and R7 is hydrogen and the other is aryl amino whereby the aryl group can be phenyl substituted by (alkyl)aminocarbonyl.;; claims 1,18 *;
 [X]US6048866  (HUTCHINGS MARTIN CLIVE [GB], et al) [X] 1 * R1 is ((di)alkyl)carbamoyl.;; claim 1 *;
 [A]WO0078731  (CELLTECH CHIROSCIENCE LTD [GB], et al) [A] 1* claim 7 *;
 [X]WO0164655  (ASTRAZENECA AB [SE], et al) [X] 1 * page 37; examples 21-30,60-98,105-107,109-113,115,117-119 *;
 [A]  - ZIMMERMANN J ET AL, "Potent and selective inhibitors of the Abl-kinase: phenylamino-pyrimidine (PAP) derivatives", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, (19970121), vol. 7, no. 2, ISSN 0960-894X, pages 187 - 192, XP004135990 [A] 1 * example 13 *

DOI:   http://dx.doi.org/10.1016/S0960-894X(96)00601-4
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.